INVESTOR AB

STOCKHOLM, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$13.72B2026 Q3
Positions7
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

INVESTOR AB reported 7 positions worth $13.72B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: AZN (60.7%). Biggest move: exit CLBT ($1.1M).

7 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AZNAstraZeneca$8.33B60.71%51,587,810——+14.0%
▸ 2 NDAQNasdaq$5.38B39.19%58,439,208——+17.9%
▸ 3 MDWDMediWound$12.0M0.09%872,093——-1.6%
▸ 4 COHRCoherent$863.4K0.01%3,000——-29.3%
▸ 5 VZVerizon Communications$619.2K0.00%13,500——+1.0%
▸ 6 MUMicron Technology$250.3K0.00%235——-32.5%
▸ 7 BMRNBiomarin Pharmaceutical$222.0K0.00%3,700——-3.3%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does INVESTOR AB hold as of Q3 2026?

INVESTOR AB reported 7 positions worth $13.72B in its Q3 2026 13F filing. Largest positions: AZN (60.7%), NDAQ (39.2%), MDWD (0.1%), COHR (0.0%) and VZ (0.0%).

What did INVESTOR AB buy in Q3 2026?

New positions: COHR. Added to: VZ.

What did INVESTOR AB sell in Q3 2026?

Reduced: MU. Sold out entirely: CLBT.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.